We are live on ! Find out more
TCP

Tyndall Capital Partners Portfolio holdings

AUM $452K
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+26.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.45M
AUM Growth
+$4.97M
Cap. Flow
+$5M
Cap. Flow %
59.22%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
PCO
Pendrell Corporation - Class A
PCO
+$3.96M
2
TRAW icon
Traws Pharma
TRAW
+$1.04M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Industrials 54.2%
2 Healthcare 25.49%
3 Financials 18.23%
4 Miscellaneous 2.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCO
1
DELISTED
Pendrell Corporation - Class A
PCO
$4.58M 54.2%
+6,334
New +$3.96M
TRAW icon
2
Traws Pharma
TRAW
$9M
$2.15M 25.49%
177
+84
+90% +$1.04M
MMAC
3
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$1.54M 18.23%
67,399
ONTXW
4
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$176K 2.08%
390,624

Similar funds

Tyndall Capital Partners's Q2 2017 Portfolio in Review

As of Q2 2017, Tyndall Capital Partners held 4 positions worth $8.45M, up 143% from $3.48M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tyndall Capital Partners deployed $5M of net new capital in Q2 2017, opening 1 new position and adding to 1 existing holding. Its largest new stake was Pendrell Corporation - Class A: 6,334 shares worth $4.58M.

By sector, the portfolio is most concentrated in Industrials at 54% of assets, followed by Healthcare and Financials.

  • Tyndall Capital Partners's largest Q2 2017 buy was Pendrell Corporation - Class A: 6,334 shares worth $4.58M.
  • Tyndall Capital Partners added most to Traws Pharma in Q2 2017, an estimated $1.04M increase.
  • Tyndall Capital Partners's ten largest holdings make up 100% of its $8.45M portfolio in Q2 2017.
  • Tyndall Capital Partners opened 1 new position and closed 0 in Q2 2017.
  • Tyndall Capital Partners's portfolio value rose 143% quarter-over-quarter to $8.45M.

Based on Tyndall Capital Partners's 13F filing for Q2 2017, filed 14 Aug 2017.